Allergan introduces hybrid injectable
Global pharmaceutical company Allergan Aesthetics has launched HArmonyCa to the UK market, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).
Global pharmaceutical company Allergan Aesthetics has launched HArmonyCa to the UK market, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).
Global pharmaceutical company Allergan Aesthetics, an AbbVie company, has entered into an exclusive development and commercialisation agreement with regenerative medicine company CollPlant to use its plant-derived recombinant human collagen.
Global pharmaceutical company Allergan Aesthetics is launchings its first body contouring system in more than 10 years.
Global pharmaceutical company Allergan Aesthetics has launched a new brand identity to empower confidence and promote diversity.
Global pharmaceutical company Allergan, an AbbVie company, has entered an agreement with privately owned aesthetics company Luminera.
Global pharmaceutical company Allergan Aesthetics and skincare company Skinbetter Science have collaborated to launch a new initiative to improve diversity in the aesthetic industry.
Fernando Alvarez has been appointed as the new UK and Ireland general manager for global pharmaceutical company Allergan Aesthetics.
Hania Flannery has been appointed as the new marketing director at Allergan Aesthetics, which was recently acquired by AbbVie.
Global biopharmaceutical company AbbVie has completed its acquisition of Allergan plc following regulatory approval of all government authorities.
American biopharmaceutical company AbbVie has agreed to buy global pharmaceutical company Allergan in a $63 billion cash and stock deal.